Singapore to Classify Etomidate as Illegal Drug Starting September 1

The Singaporean government will classify etomidate, an anaesthetic agent recently discovered in vaping products, as a controlled substance under the Misuse of Drugs Act effective September 1, 2023. Minister for Health Ong Ye Kung announced this decision on August 24, indicating that etomidate will be categorized as a Class C drug. This classification makes it illegal to traffic, manufacture, import, export, possess, or consume etomidate without proper authorization.

Under the Misuse of Drugs Act, substances are divided into three classes, with Class A being the most strictly controlled. Class A drugs include heroin, cocaine, and cannabis, while Class C drugs represent a lesser degree of control. The government’s move follows increased concerns over vaping and the safety of the substances used in these products.

In his comments to journalists at an event hosted by the Agency for Integrated Care, Ong stated that further details regarding the classification would be shared at a press conference scheduled for August 28. This announcement aligns with recent efforts by the Singaporean government to combat the growing issue of vaping, highlighted by Prime Minister Lawrence Wong during his National Day Rally speech on August 17.

Authorities conducted random tests on over 100 seized vapes, revealing that approximately one-third contained etomidate. The vaping products that include etomidate are commonly referred to as Kpods. Vaping remains illegal in Singapore, encompassing both domestic and international purchases, along with the import, distribution, and sale of vaping devices and their components.

The recent crackdown on vaping is part of a broader initiative by the government to address public health concerns. Wong emphasized that the approach to vaping will be treated as a “drug issue,” leading to more stringent penalties. These include potential jail sentences and heightened consequences for those involved in selling vapes containing harmful substances.

Currently, etomidate is regulated under the Poisons Act, which allows for fines against users of drug-laced pods. However, this status will change once etomidate is officially listed under the Misuse of Drugs Act. Ong noted that individuals using etomidate-laced products will face consequences similar to those consuming hard drugs, such as cannabis or cocaine. This shift will require mandatory rehabilitation and may involve commitment to drug rehabilitation centres.

As Singapore intensifies its enforcement against vaping, the classification of etomidate marks a significant step in addressing the potential risks associated with these products. The government aims to safeguard public health while discouraging the use of substances that could lead to addiction or other health issues.